CLINICAL TRIALS PROFILE FOR TRETINOIN MICROSPHERE
✉ Email this page to a colleague
All Clinical Trials for TRETINOIN MICROSPHERE
Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
---|---|---|---|---|---|---|
NCT00907257 ↗ | A Study of Different Use Regimens Using Two Acne Treatments | Completed | Bausch Health Americas, Inc. | Phase 4 | 2009-02-01 | A study to determine if using 2 acne products in the morning is as safe and efficacious as using one product in the morning and one product in the evening. |
NCT00907257 ↗ | A Study of Different Use Regimens Using Two Acne Treatments | Completed | Valeant Pharmaceuticals International, Inc. | Phase 4 | 2009-02-01 | A study to determine if using 2 acne products in the morning is as safe and efficacious as using one product in the morning and one product in the evening. |
NCT00939133 ↗ | Proof of Concept Study to Investigate the Recurrence of Acne Post Isotretinoin | Completed | Johnson & Johnson | Phase 4 | 2009-07-01 | The use of topical retinoids is a mainstay and basis of early acne treatment to prevent the progression to inflammatory lesions. Post oral isotretinoin, it is not uncommon for non-inflammatory papules and comedones to recur. However, there has been no formal study to look at the prevention of recurrence of these acne lesions post isotretinoin in a long term basis. This may enhance the therapeutic options for post isotretinoin patients in order to prevent recurrence of their disease. Hypothesis Tretinoin microsphere 0.04% will prevent recurrence of acne lesions. |
>Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for TRETINOIN MICROSPHERE
Condition Name
Clinical Trial Locations for TRETINOIN MICROSPHERE
Trials by Country
Clinical Trial Progress for TRETINOIN MICROSPHERE
Clinical Trial Phase
Clinical Trial Sponsors for TRETINOIN MICROSPHERE
Sponsor Name